Article
Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidates
2023-06-29
Abstract excerpt
Splicing is dysregulated in many tumors and may result in tumor-specific transcripts that can encode neoantigens, which are promising targets for cancer immunotherapy. Detecting tumor-specific splicing is challenging because many non-canonical splice junctions identified in tumor transcriptomes also appear in healthy tissues. Here, we developed splice2neo to integrate the predicted splice effects from somatic muta...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 84adb2ba-0344-594f-ba78-8a098debd698
- DOI
- 10.1101/2023.06.27.546494
